December 25, 2014 4:39 AM ET

Pharmaceuticals

Company Overview of Bionaut Pharmaceuticals, Inc.

Executive Profile

H. Earl Ruley Ph.D.

Member of Scienctific Advisory Board, Bionaut Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 1 different industries.

See Board Relationships
----

Background

H. Earl Ruley,Ph.D. is a co-founder of Avatar Biosciences and TransCell Therapeutics, Inc. Dr. Ruley serves as an Editor of Oncogene.Dr. Ruley serves as Professor of Microbiology and Immunology and Ingram Professor of Cancer Research at the Vanderbilt University School of Medicine. He served as an Acting Director of the tumor biology program at Schering Plough Corp. He has held positions as Staff Scientist at the Cold Spring Harbor Laboratory and Assistant and Associate ...

Corporate Headquarters

One Broadway
Cambridge, Massachusetts 02142

United States

Phone: 617-401-2215
Fax: 617-758-4101

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
University Of North Carolina At Chapel Hill

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Bionaut Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.